Infectious Disease Diagnostic Market
Infectious Disease Diagnostic Market Study by CNS Infection, Diarrhoeal Disease, Respiratory Infections, Blood Infections, and STDs from 2024 to 2034
Analysis of Infectious Disease Diagnostic Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Infectious Disease Diagnostic Market Outlook (2024 to 2034)
The global infectious disease diagnostic market size is valued at US$ 1,503.8 million in 2024, and it is estimated to expand at a 7.1% CAGR, reaching a valuation of US$ 2,978.7 million by 2034.
Molecular diagnostics, quick testing, automation, and other advancements in diagnostic technology have greatly increased the precision, speed, and effectiveness of diagnosing infectious diseases. Through the provision of improved instruments for the early identification and surveillance of infectious illnesses, these advances support the market's expansion. Infectious diseases, especially new and re-emerging infections, are growing increasingly prevalent globally. As a result, there is a greater demand for precision diagnostic technologies that enable early identification and intervention.
Key Trends Boosting Infectious Disease Diagnostic Market Growth
“Rising Adoption of Point-of-Care Technologies (POCT)”
The growing use of Point-of-Care Testing (POCT) indicates a deliberate move away from centralized diagnostic solutions and toward decentralized ones, which enable companies to meet customer demands for quick and convenient diagnostics. This trend gives businesses that offer POCT solutions a competitive edge by facilitating speedier decision-making and patient management. It also corresponds with market expectations for effective healthcare delivery in resource-constrained environments.
“Growing Advancements in Next-generation Sequencing (NGS)”
Businesses that specialize in the diagnosis of infectious diseases are making use of Next-Generation Sequencing (NGS) technology developments. Businesses are offering innovative solutions to meet the increasing need for genetic diversity studies in infectious agents and comprehensive surveillance applications by integrating quicker and more affordable sequencing capabilities.
“Rising Focus on Antimicrobial Resistance (AMR)”
It is strategically vital for firms to develop diagnostic tests that can promptly identify drug-resistant types of bacteria, given growing concerns over antimicrobial resistance (AMR). Businesses that match their products to this niche must proactively position themselves to tackle a pressing issue in global health by delivering solutions that support efficient administration and treatment.
“Growing Demand for Rapid Diagnostic Tests (RDTs)”
Rapid Diagnostic Tests (RDTs) are in high demand, creating significant possibilities for enterprises to profit from the need for swift and on-the-spot reports in point-of-care settings. Businesses can develop a strong competitive advantage and fulfill the changing needs of healthcare professionals and end-users by delivering solutions that guarantee fast decision-making and effective patient management.
| Report Attributes | Details |
|---|---|
| Estimated Market Value (2024E) | US$ 1,503.8 million |
| Forecasted Market Value (2034F) | US$ 2,987.7 million |
| Global Market Growth Rate (2024 to 2034) | 7.1% CAGR |
| STDs Disease Indication Segment Growth Rate (2024 to 2034) | 8.3% |
| Cell Culture Technique Segment Growth Rate (2024 to 2034) | 8.3% |
| North America Market Share (2024) | 20.9% |
| East Asia Market Share (2024) | 17.7% |
| Key Companies Profiled |
|
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Which Factors Are Boosting the Demand for Infectious Disease Diagnostics?
“Emergence of Zoonotic Diseases and Environmental Changes”
Urbanization and climate change are two environmental changes that lead to the rise of zoonotic illnesses. Businesses that provide zoonotic diagnostic services can differentiate themselves by comprehending the relationship between disease transmission dynamics and environmental changes. This entails creating diagnostic instruments that target zoonotic pathogens specifically, meeting a particular market demand, and positioning the business as a pioneer in the rapidly changing field of infectious disease diagnostics.
“Rising Emphasis on Preventive Healthcare Measures”
The focus on preventative healthcare highlights the need for transmissible disease diagnostics as essential to regular physical examinations. Companies that correlate their offerings with this trend portray themselves as indispensable for proactive health management. This includes marketing initiatives highlighting the importance of diagnostics in early detection and prevention, generating a favorable view of the company's capabilities among healthcare providers and end-users. These firms encourage market development by promoting diagnostic products as key components of wellness plans.
“Global Focus on Prioritizing Health Security”
The growing risk of epidemics and bioterrorism has prompted governments and international organizations to place a high priority on global health security. In order to improve epidemic preparedness and response capacities, significant investments are required in cutting-edge infectious disease diagnostics. Businesses that strategically link their offerings with these global health security initiatives stand to gain from increased demand for state-of-the-art diagnostic solutions, giving them a competitive edge in a market where public health concerns drive demand.
Which Factors Restrain this Market’s Growth Prospects?
“Disparities in Global Healthcare Infrastructure”
Differences hamper the general embrace of modern technology in the diagnostic and medical infrastructure across developed and developing regions. Underprivileged populations are susceptible to delayed or insufficient identification and treatment of infectious illnesses as a result of limited resources in some regions of the world, thereby impeding the broad use of advanced diagnostic methods.
“Growing Antibiotic Resistance in Patients”
The growing issue of antibiotic resistance makes diagnosing infectious diseases more difficult. Finding appropriate medicines is harder when infections develop resistance to standard therapies. When it comes to helping medical practitioners prescribe focused and successful drugs, diagnostic tools need to be updated regularly. To stay up with the ever-changing risks posed by microorganisms, diagnostics must constantly innovate due to the growing intricacy of antibiotic resistance patterns.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Country-wise Insights
The United States infectious disease diagnostic market is anticipated to witness significant expansion, leading at a 6.7% CAGR through 2034 in North America. According to estimates, China is anticipated to lead the East Asia infectious disease diagnostic market with an 8.7% CAGR until 2034.
Why is the Demand Expanding in the United States?
“Growing Emphasis on Preventive Care Boosts Demand in the United States”
| Country | Value CAGR (2024 to 2034) |
|---|---|
| United States | 6.7% |
The demand for infectious disease diagnostics in the United States is poised to rise at a 6.7% CAGR through 2034. The market growth in the United States is influenced by the shift in healthcare policies that emphasize preventative treatment. Deploying value-based care models and reimbursement processes incentivizing early identification and intervention provides a conducive environment. Diagnostic firms that carefully match their products with preventive healthcare goals stand to gain from the increasing emphasis on cost-effective and proactive healthcare procedures. This change accommodates changing patient preferences and positions enterprises as contributors to larger healthcare goals, strengthening their market presence in the volatile American healthcare sector.
Why is Demand Surging in China at a Higher CAGR?
“Rising Health Consciousness Trends Nurture Growth in China”
| Country | Value CAGR (2024 to 2034) |
|---|---|
| China | 8.7% |
The infectious disease diagnostics market in China is estimated to have an 8.7% CAGR through 2034. The rising middle-class population in China and a growing health-consciousness trend are driving market expansion for infectious disease diagnostics. As people grow more health-conscious, there is a greater need for preventative healthcare interventions, such as early illness diagnosis. Diagnostic firms that promote their goods as essential to health-conscious lifestyles benefit from this trend. This entails strategic marketing initiatives that emphasize the relevance of diagnostics in preventative healthcare, thereby reflecting the ideals and ambitions of China's increasing middle-class populace.
Category-wise Insights
Why are STDs the Leading Disease Indication Segment?
“Technological Advancements Boost Demand for STD Diagnostics”
| Attribute | STDs (Disease Indication) |
|---|---|
| Segment Value (2024E) | US$ 532.5 million |
| Growth Rate (2024 to 2034) | 8.3% CAGR |
| Projected Value (2034F) | US$ 1,176.7 million |
STD diagnostics are in high demand due in part to ongoing developments in diagnostic technology. Increased test sensitivity and specificity, quick diagnostic techniques, and creating point-of-care testing choices improve the entire diagnostic experience. The availability of effective and user-friendly diagnostic equipment motivates more people to be tested.
Several STDs, such as gonorrhea and chlamydia, can exhibit no symptoms at all, which makes infections go undiagnosed and untreated. Given that people aren't always aware of their infection status, the high incidence of asymptomatic infections highlights the significance of routine testing. The growing need for tests that can identify infections even without symptoms is partly due to diagnostic businesses' response to this requirement.
Why is Cell Culture the Leading Technique in this Market?
“Critical Role in Developing Novel Therapies Surges Demand for Cell Culture Technique”
| Attribute | Cell Culture (Technique) |
|---|---|
| Segment Value (2024E) | US$ 588.7 million |
| Growth Rate (2024 to 2034) | 8.3% CAGR |
| Projected Value (2034F) | US$ 1,304.6 million |
Cell culture techniques play an important role in the industry in developing innovative treatment strategies such as cell-based therapeutics and personalized healthcare approaches. Infectious disease diagnostics involves researching novel treatments such as viral vector-based therapeutics and cell-based immunotherapies. Cell culture is in high demand due to its critical role in the advancement of these cutting-edge treatment techniques.
New developments in three-dimensional (3D) cell culture models improve the precision and applicability of studies on infectious diseases. By more closely resembling the intricate milieu of tissues and organs, these models enable researchers to examine infections in a more physiologically relevant setting. The rapid increase in the demand for 3D cell culture indicates the industry's dedication to developing research methods for an improved understanding of infectious illnesses.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Competitive Landscape
Key players in the infectious disease diagnostic market include Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Thermo Fisher Scientific, BioMérieux SA, Becton, Dickinson and Company, Cepheid (a Danaher Corporation company), Hologic, Inc., QIAGEN N.V., Bio-Rad Laboratories, Inc., Luminex Corporation, Ortho Clinical Diagnostics, DiaSorin S.p.A., Meridian Bioscience, Inc., and GenMark Diagnostics, Inc.
The infectious disease diagnostic market is highly competitive, with significant rivals fighting for market share and innovation supremacy. Market leaders concentrate on smart mergers and acquisitions to increase their global reach, add specialized technology, and diversify their product offerings. They hope to improve their competitive standing and increase their market reach by taking these calculated risks.
Recent Developments
- In November 2023, Apollo Cancer Centres (ACCs) launched ‘India's Fastest & Precise Breast Cancer Diagnosis Program.’ This project seeks to deliver rapid and accurate breast cancer diagnostics, emphasizing the importance of early diagnosis in determining the best therapy for patients and improving their quality of life.
- In October 2023, Precede Biosciences entered the market with cell-free genomic diagnostics for drug development and precision medicine.
Infectious Disease Diagnostic Market Segmentation
-
By Disease Indication:
- CNS Infection
- Diarrhoeal Disease
- Respiratory Infections
- Blood Infections
- STDs
-
By Technique:
- ELISA
- Polymerase Chain Reaction
- Immunoassays
- Cell Cultures
- Others
-
By End User:
- Hospitals
- Diagnostic Centers
- Clinics
- Government Organizations
-
By Region:
- North America
- Europe
- Latin America
- East Asia
- South Asia & Oceania
- The Middle East & Africa
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034 4.1. Historical Market Size Value (US$ Million) Analysis, 2019 to 2023 4.2. Current and Future Market Size Value (US$ Million) Projections, 2024 to 2034 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2019 to 2023 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2024 to 2034 5.3.1. Assays & Reagents 5.3.2. Instruments 5.3.3. Software 5.4. Y-o-Y Growth Trend Analysis By Product, 2019 to 2023 5.5. Absolute $ Opportunity Analysis By Product, 2024 to 2034 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Disease Type 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Disease Type, 2019 to 2023 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Disease Type, 2024 to 2034 6.3.1. Hepatitis 6.3.2. Human Immunodeficiency Virus 6.3.3. Influenza 6.3.4. Others 6.4. Y-o-Y Growth Trend Analysis By Disease Type, 2019 to 2023 6.5. Absolute $ Opportunity Analysis By Disease Type, 2024 to 2034 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Technology 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By Technology, 2019 to 2023 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Technology, 2024 to 2034 7.3.1. Immunodiagnostics 7.3.2. Clinical Microbiology 7.3.3. Polymerase Chain Reaction 7.3.4. Next Generation Sequencing 7.3.5. Others 7.4. Y-o-Y Growth Trend Analysis By Technology, 2019 to 2023 7.5. Absolute $ Opportunity Analysis By Technology, 2024 to 2034 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2019 to 2023 8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2024 to 2034 8.3.1. North America 8.3.2. Latin America 8.3.3. Western Europe 8.3.4. Eastern Europe 8.3.5. South Asia and Pacific 8.3.6. East Asia 8.3.7. Middle East and Africa 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 9.2.1. By Country 9.2.1.1. U.S. 9.2.1.2. Canada 9.2.2. By Product 9.2.3. By Disease Type 9.2.4. By Technology 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product 9.3.3. By Disease Type 9.3.4. By Technology 9.4. Key Takeaways 10. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Product 10.2.3. By Disease Type 10.2.4. By Technology 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product 10.3.3. By Disease Type 10.3.4. By Technology 10.4. Key Takeaways 11. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. U.K. 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Western Europe 11.2.2. By Product 11.2.3. By Disease Type 11.2.4. By Technology 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product 11.3.3. By Disease Type 11.3.4. By Technology 11.4. Key Takeaways 12. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 12.2.1. By Country 12.2.1.1. Poland 12.2.1.2. Russia 12.2.1.3. Czech Republic 12.2.1.4. Romania 12.2.1.5. Rest of Eastern Europe 12.2.2. By Product 12.2.3. By Disease Type 12.2.4. By Technology 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product 12.3.3. By Disease Type 12.3.4. By Technology 12.4. Key Takeaways 13. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 13.2.1. By Country 13.2.1.1. India 13.2.1.2. Bangladesh 13.2.1.3. Australia 13.2.1.4. New Zealand 13.2.1.5. Rest of South Asia and Pacific 13.2.2. By Product 13.2.3. By Disease Type 13.2.4. By Technology 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product 13.3.3. By Disease Type 13.3.4. By Technology 13.4. Key Takeaways 14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 14.2.1. By Country 14.2.1.1. China 14.2.1.2. Japan 14.2.1.3. South Korea 14.2.2. By Product 14.2.3. By Disease Type 14.2.4. By Technology 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product 14.3.3. By Disease Type 14.3.4. By Technology 14.4. Key Takeaways 15. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Israel 15.2.1.4. Rest of MEA 15.2.2. By Product 15.2.3. By Disease Type 15.2.4. By Technology 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Product 15.3.3. By Disease Type 15.3.4. By Technology 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. U.S. 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2023 16.1.2.1. By Product 16.1.2.2. By Disease Type 16.1.2.3. By Technology 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2023 16.2.2.1. By Product 16.2.2.2. By Disease Type 16.2.2.3. By Technology 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2023 16.3.2.1. By Product 16.3.2.2. By Disease Type 16.3.2.3. By Technology 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2023 16.4.2.1. By Product 16.4.2.2. By Disease Type 16.4.2.3. By Technology 16.5. Germany 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2023 16.5.2.1. By Product 16.5.2.2. By Disease Type 16.5.2.3. By Technology 16.6. U.K. 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2023 16.6.2.1. By Product 16.6.2.2. By Disease Type 16.6.2.3. By Technology 16.7. France 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2023 16.7.2.1. By Product 16.7.2.2. By Disease Type 16.7.2.3. By Technology 16.8. Spain 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2023 16.8.2.1. By Product 16.8.2.2. By Disease Type 16.8.2.3. By Technology 16.9. Italy 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2023 16.9.2.1. By Product 16.9.2.2. By Disease Type 16.9.2.3. By Technology 16.10. Poland 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2023 16.10.2.1. By Product 16.10.2.2. By Disease Type 16.10.2.3. By Technology 16.11. Russia 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2023 16.11.2.1. By Product 16.11.2.2. By Disease Type 16.11.2.3. By Technology 16.12. Czech Republic 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2023 16.12.2.1. By Product 16.12.2.2. By Disease Type 16.12.2.3. By Technology 16.13. Romania 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2023 16.13.2.1. By Product 16.13.2.2. By Disease Type 16.13.2.3. By Technology 16.14. India 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2023 16.14.2.1. By Product 16.14.2.2. By Disease Type 16.14.2.3. By Technology 16.15. Bangladesh 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2023 16.15.2.1. By Product 16.15.2.2. By Disease Type 16.15.2.3. By Technology 16.16. Australia 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2023 16.16.2.1. By Product 16.16.2.2. By Disease Type 16.16.2.3. By Technology 16.17. New Zealand 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2023 16.17.2.1. By Product 16.17.2.2. By Disease Type 16.17.2.3. By Technology 16.18. China 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2023 16.18.2.1. By Product 16.18.2.2. By Disease Type 16.18.2.3. By Technology 16.19. Japan 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2023 16.19.2.1. By Product 16.19.2.2. By Disease Type 16.19.2.3. By Technology 16.20. South Korea 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2023 16.20.2.1. By Product 16.20.2.2. By Disease Type 16.20.2.3. By Technology 16.21. GCC Countries 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2023 16.21.2.1. By Product 16.21.2.2. By Disease Type 16.21.2.3. By Technology 16.22. South Africa 16.22.1. Pricing Analysis 16.22.2. Market Share Analysis, 2023 16.22.2.1. By Product 16.22.2.2. By Disease Type 16.22.2.3. By Technology 16.23. Israel 16.23.1. Pricing Analysis 16.23.2. Market Share Analysis, 2023 16.23.2.1. By Product 16.23.2.2. By Disease Type 16.23.2.3. By Technology 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Product 17.3.3. By Disease Type 17.3.4. By Technology 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Abbott Laboratories 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.2. Becton Dickinson and Company 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.3. bioMerieus SA 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.4. Bio-Rad Laboratories 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.5. Danaher Corporation 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.6. F Hoffman-La Roche 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.7. Hologic Inc. 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.8. Luminex Corporation 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.9. Qiagen Inc. 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.10. Thermo Fisher Scientific Inc. 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Market Value (US$ Million) Forecast by Region, 2019 to 2034
Table 2: Global Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 3: Global Market Value (US$ Million) Forecast by Disease Type, 2019 to 2034
Table 4: Global Market Value (US$ Million) Forecast by Technology, 2019 to 2034
Table 5: North America Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 6: North America Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 7: North America Market Value (US$ Million) Forecast by Disease Type, 2019 to 2034
Table 8: North America Market Value (US$ Million) Forecast by Technology, 2019 to 2034
Table 9: Latin America Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 10: Latin America Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 11: Latin America Market Value (US$ Million) Forecast by Disease Type, 2019 to 2034
Table 12: Latin America Market Value (US$ Million) Forecast by Technology, 2019 to 2034
Table 13: Western Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 14: Western Europe Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 15: Western Europe Market Value (US$ Million) Forecast by Disease Type, 2019 to 2034
Table 16: Western Europe Market Value (US$ Million) Forecast by Technology, 2019 to 2034
Table 17: Eastern Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 18: Eastern Europe Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 19: Eastern Europe Market Value (US$ Million) Forecast by Disease Type, 2019 to 2034
Table 20: Eastern Europe Market Value (US$ Million) Forecast by Technology, 2019 to 2034
Table 21: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 22: South Asia and Pacific Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 23: South Asia and Pacific Market Value (US$ Million) Forecast by Disease Type, 2019 to 2034
Table 24: South Asia and Pacific Market Value (US$ Million) Forecast by Technology, 2019 to 2034
Table 25: East Asia Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 26: East Asia Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 27: East Asia Market Value (US$ Million) Forecast by Disease Type, 2019 to 2034
Table 28: East Asia Market Value (US$ Million) Forecast by Technology, 2019 to 2034
Table 29: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 30: Middle East and Africa Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 31: Middle East and Africa Market Value (US$ Million) Forecast by Disease Type, 2019 to 2034
Table 32: Middle East and Africa Market Value (US$ Million) Forecast by Technology, 2019 to 2034
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Market Value (US$ Million) by Product, 2024 to 2034
Figure 2: Global Market Value (US$ Million) by Disease Type, 2024 to 2034
Figure 3: Global Market Value (US$ Million) by Technology, 2024 to 2034
Figure 4: Global Market Value (US$ Million) by Region, 2024 to 2034
Figure 5: Global Market Value (US$ Million) Analysis by Region, 2019 to 2034
Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2024 to 2034
Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2024 to 2034
Figure 8: Global Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 9: Global Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 10: Global Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 11: Global Market Value (US$ Million) Analysis by Disease Type, 2019 to 2034
Figure 12: Global Market Value Share (%) and BPS Analysis by Disease Type, 2024 to 2034
Figure 13: Global Market Y-o-Y Growth (%) Projections by Disease Type, 2024 to 2034
Figure 14: Global Market Value (US$ Million) Analysis by Technology, 2019 to 2034
Figure 15: Global Market Value Share (%) and BPS Analysis by Technology, 2024 to 2034
Figure 16: Global Market Y-o-Y Growth (%) Projections by Technology, 2024 to 2034
Figure 17: Global Market Attractiveness by Product, 2024 to 2034
Figure 18: Global Market Attractiveness by Disease Type, 2024 to 2034
Figure 19: Global Market Attractiveness by Technology, 2024 to 2034
Figure 20: Global Market Attractiveness by Region, 2024 to 2034
Figure 21: North America Market Value (US$ Million) by Product, 2024 to 2034
Figure 22: North America Market Value (US$ Million) by Disease Type, 2024 to 2034
Figure 23: North America Market Value (US$ Million) by Technology, 2024 to 2034
Figure 24: North America Market Value (US$ Million) by Country, 2024 to 2034
Figure 25: North America Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 28: North America Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 29: North America Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 30: North America Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 31: North America Market Value (US$ Million) Analysis by Disease Type, 2019 to 2034
Figure 32: North America Market Value Share (%) and BPS Analysis by Disease Type, 2024 to 2034
Figure 33: North America Market Y-o-Y Growth (%) Projections by Disease Type, 2024 to 2034
Figure 34: North America Market Value (US$ Million) Analysis by Technology, 2019 to 2034
Figure 35: North America Market Value Share (%) and BPS Analysis by Technology, 2024 to 2034
Figure 36: North America Market Y-o-Y Growth (%) Projections by Technology, 2024 to 2034
Figure 37: North America Market Attractiveness by Product, 2024 to 2034
Figure 38: North America Market Attractiveness by Disease Type, 2024 to 2034
Figure 39: North America Market Attractiveness by Technology, 2024 to 2034
Figure 40: North America Market Attractiveness by Country, 2024 to 2034
Figure 41: Latin America Market Value (US$ Million) by Product, 2024 to 2034
Figure 42: Latin America Market Value (US$ Million) by Disease Type, 2024 to 2034
Figure 43: Latin America Market Value (US$ Million) by Technology, 2024 to 2034
Figure 44: Latin America Market Value (US$ Million) by Country, 2024 to 2034
Figure 45: Latin America Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 48: Latin America Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 49: Latin America Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 51: Latin America Market Value (US$ Million) Analysis by Disease Type, 2019 to 2034
Figure 52: Latin America Market Value Share (%) and BPS Analysis by Disease Type, 2024 to 2034
Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Disease Type, 2024 to 2034
Figure 54: Latin America Market Value (US$ Million) Analysis by Technology, 2019 to 2034
Figure 55: Latin America Market Value Share (%) and BPS Analysis by Technology, 2024 to 2034
Figure 56: Latin America Market Y-o-Y Growth (%) Projections by Technology, 2024 to 2034
Figure 57: Latin America Market Attractiveness by Product, 2024 to 2034
Figure 58: Latin America Market Attractiveness by Disease Type, 2024 to 2034
Figure 59: Latin America Market Attractiveness by Technology, 2024 to 2034
Figure 60: Latin America Market Attractiveness by Country, 2024 to 2034
Figure 61: Western Europe Market Value (US$ Million) by Product, 2024 to 2034
Figure 62: Western Europe Market Value (US$ Million) by Disease Type, 2024 to 2034
Figure 63: Western Europe Market Value (US$ Million) by Technology, 2024 to 2034
Figure 64: Western Europe Market Value (US$ Million) by Country, 2024 to 2034
Figure 65: Western Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 66: Western Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 67: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 68: Western Europe Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 69: Western Europe Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 70: Western Europe Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 71: Western Europe Market Value (US$ Million) Analysis by Disease Type, 2019 to 2034
Figure 72: Western Europe Market Value Share (%) and BPS Analysis by Disease Type, 2024 to 2034
Figure 73: Western Europe Market Y-o-Y Growth (%) Projections by Disease Type, 2024 to 2034
Figure 74: Western Europe Market Value (US$ Million) Analysis by Technology, 2019 to 2034
Figure 75: Western Europe Market Value Share (%) and BPS Analysis by Technology, 2024 to 2034
Figure 76: Western Europe Market Y-o-Y Growth (%) Projections by Technology, 2024 to 2034
Figure 77: Western Europe Market Attractiveness by Product, 2024 to 2034
Figure 78: Western Europe Market Attractiveness by Disease Type, 2024 to 2034
Figure 79: Western Europe Market Attractiveness by Technology, 2024 to 2034
Figure 80: Western Europe Market Attractiveness by Country, 2024 to 2034
Figure 81: Eastern Europe Market Value (US$ Million) by Product, 2024 to 2034
Figure 82: Eastern Europe Market Value (US$ Million) by Disease Type, 2024 to 2034
Figure 83: Eastern Europe Market Value (US$ Million) by Technology, 2024 to 2034
Figure 84: Eastern Europe Market Value (US$ Million) by Country, 2024 to 2034
Figure 85: Eastern Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 86: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 87: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 88: Eastern Europe Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 89: Eastern Europe Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 90: Eastern Europe Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 91: Eastern Europe Market Value (US$ Million) Analysis by Disease Type, 2019 to 2034
Figure 92: Eastern Europe Market Value Share (%) and BPS Analysis by Disease Type, 2024 to 2034
Figure 93: Eastern Europe Market Y-o-Y Growth (%) Projections by Disease Type, 2024 to 2034
Figure 94: Eastern Europe Market Value (US$ Million) Analysis by Technology, 2019 to 2034
Figure 95: Eastern Europe Market Value Share (%) and BPS Analysis by Technology, 2024 to 2034
Figure 96: Eastern Europe Market Y-o-Y Growth (%) Projections by Technology, 2024 to 2034
Figure 97: Eastern Europe Market Attractiveness by Product, 2024 to 2034
Figure 98: Eastern Europe Market Attractiveness by Disease Type, 2024 to 2034
Figure 99: Eastern Europe Market Attractiveness by Technology, 2024 to 2034
Figure 100: Eastern Europe Market Attractiveness by Country, 2024 to 2034
Figure 101: South Asia and Pacific Market Value (US$ Million) by Product, 2024 to 2034
Figure 102: South Asia and Pacific Market Value (US$ Million) by Disease Type, 2024 to 2034
Figure 103: South Asia and Pacific Market Value (US$ Million) by Technology, 2024 to 2034
Figure 104: South Asia and Pacific Market Value (US$ Million) by Country, 2024 to 2034
Figure 105: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 106: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 107: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 108: South Asia and Pacific Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 109: South Asia and Pacific Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 110: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 111: South Asia and Pacific Market Value (US$ Million) Analysis by Disease Type, 2019 to 2034
Figure 112: South Asia and Pacific Market Value Share (%) and BPS Analysis by Disease Type, 2024 to 2034
Figure 113: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Disease Type, 2024 to 2034
Figure 114: South Asia and Pacific Market Value (US$ Million) Analysis by Technology, 2019 to 2034
Figure 115: South Asia and Pacific Market Value Share (%) and BPS Analysis by Technology, 2024 to 2034
Figure 116: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Technology, 2024 to 2034
Figure 117: South Asia and Pacific Market Attractiveness by Product, 2024 to 2034
Figure 118: South Asia and Pacific Market Attractiveness by Disease Type, 2024 to 2034
Figure 119: South Asia and Pacific Market Attractiveness by Technology, 2024 to 2034
Figure 120: South Asia and Pacific Market Attractiveness by Country, 2024 to 2034
Figure 121: East Asia Market Value (US$ Million) by Product, 2024 to 2034
Figure 122: East Asia Market Value (US$ Million) by Disease Type, 2024 to 2034
Figure 123: East Asia Market Value (US$ Million) by Technology, 2024 to 2034
Figure 124: East Asia Market Value (US$ Million) by Country, 2024 to 2034
Figure 125: East Asia Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 126: East Asia Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 127: East Asia Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 128: East Asia Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 129: East Asia Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 130: East Asia Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 131: East Asia Market Value (US$ Million) Analysis by Disease Type, 2019 to 2034
Figure 132: East Asia Market Value Share (%) and BPS Analysis by Disease Type, 2024 to 2034
Figure 133: East Asia Market Y-o-Y Growth (%) Projections by Disease Type, 2024 to 2034
Figure 134: East Asia Market Value (US$ Million) Analysis by Technology, 2019 to 2034
Figure 135: East Asia Market Value Share (%) and BPS Analysis by Technology, 2024 to 2034
Figure 136: East Asia Market Y-o-Y Growth (%) Projections by Technology, 2024 to 2034
Figure 137: East Asia Market Attractiveness by Product, 2024 to 2034
Figure 138: East Asia Market Attractiveness by Disease Type, 2024 to 2034
Figure 139: East Asia Market Attractiveness by Technology, 2024 to 2034
Figure 140: East Asia Market Attractiveness by Country, 2024 to 2034
Figure 141: Middle East and Africa Market Value (US$ Million) by Product, 2024 to 2034
Figure 142: Middle East and Africa Market Value (US$ Million) by Disease Type, 2024 to 2034
Figure 143: Middle East and Africa Market Value (US$ Million) by Technology, 2024 to 2034
Figure 144: Middle East and Africa Market Value (US$ Million) by Country, 2024 to 2034
Figure 145: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 146: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 147: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 148: Middle East and Africa Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 149: Middle East and Africa Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 150: Middle East and Africa Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 151: Middle East and Africa Market Value (US$ Million) Analysis by Disease Type, 2019 to 2034
Figure 152: Middle East and Africa Market Value Share (%) and BPS Analysis by Disease Type, 2024 to 2034
Figure 153: Middle East and Africa Market Y-o-Y Growth (%) Projections by Disease Type, 2024 to 2034
Figure 154: Middle East and Africa Market Value (US$ Million) Analysis by Technology, 2019 to 2034
Figure 155: Middle East and Africa Market Value Share (%) and BPS Analysis by Technology, 2024 to 2034
Figure 156: Middle East and Africa Market Y-o-Y Growth (%) Projections by Technology, 2024 to 2034
Figure 157: Middle East and Africa Market Attractiveness by Product, 2024 to 2034
Figure 158: Middle East and Africa Market Attractiveness by Disease Type, 2024 to 2034
Figure 159: Middle East and Africa Market Attractiveness by Technology, 2024 to 2034
Figure 160: Middle East and Africa Market Attractiveness by Country, 2024 to 2034
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How Big is the Infectious Disease Diagnostic Market?
The infectious disease diagnostic market size is valued at US$ 1,503.8 million in 2024.
What is the Projected CAGR of the Infectious Disease Diagnostic Market?
The infectious disease diagnostic market is likely to rise at a 7.1% CAGR through 2034.
What is the Growth Potential of the Infectious Disease Diagnostic Market by 2034?
The infectious disease diagnostic market is expected to be worth US$ 2,987.7 million by 2034.
Which is the Leading Technique in the Infectious Disease Diagnostic Market?
Cell culture technique witnesses high demand in the industry.
Which Country is Rising at a Higher CAGR in the Infectious Disease Diagnostic Market?
The infectious disease diagnostic market in China is predicted to rise at an 8.7% CAGR through 2034.
Infectious Disease Diagnostic Market